295 related articles for article (PubMed ID: 17460355)
1. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
[TBL] [Abstract][Full Text] [Related]
2. Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study.
Iwamoto J; Takeda T; Sato Y; Yeh JK
J Bone Miner Metab; 2007; 25(1):46-53. PubMed ID: 17187193
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of vitamin K2 and prostaglandin E2 on cancellous bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Calcif Tissue Int; 2006 Nov; 79(5):318-25. PubMed ID: 17048065
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
6. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study.
Iwamoto J; Matsumoto H; Tadeda T; Sato Y; Yeh JK
Yonsei Med J; 2009 Apr; 50(2):189-94. PubMed ID: 19430549
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
9. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
10. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
11. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
[TBL] [Abstract][Full Text] [Related]
13. Histologic evidence: growth hormone completely prevents reduction in cortical bone gain and partially prevents cancellous osteopenia in the tibia of hypophysectomized rats.
Chen MM; Yeh JK; Aloia JF
Anat Rec; 1997 Oct; 249(2):163-72. PubMed ID: 9335461
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
Kidder LS; Schmidt IU; Evans GL; Turner RT
Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K(2) improves renal function and increases femoral bone strength in rats with renal insufficiency.
Iwamoto J; Seki A; Sato Y; Matsumoto H
Calcif Tissue Int; 2012 Jan; 90(1):50-9. PubMed ID: 22080166
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency.
Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK
Bone; 2011 May; 48(5):1015-21. PubMed ID: 21352961
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K2 improves femoral bone strength without altering bone mineral density in gastrectomized rats.
Iwamoto J; Sato Y; Matsumoto H
J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):71-7. PubMed ID: 24975215
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Yeh JK
Calcif Tissue Int; 2010 Sep; 87(3):254-62. PubMed ID: 20556371
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of growth hormone and alpha calcidol on trabecular and cortical bones in hypophysectomized rats.
Chaudhry AA; Castro-Magana M; Aloia JF; Yeh JK
Pediatr Res; 2009 Apr; 65(4):403-8. PubMed ID: 19092717
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
